FDA Inspection 1097717 — UAMS ART Program Tissue Bank
The FDA completed an inspection of UAMS ART Program Tissue Bank on June 26, 2019 in Little Rock, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 26, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Little Rock, AR (United States)